|
Category: natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Specific Gravity: | 0.85900 to 0.86200 @ 20.00 °C.
|
| Pounds per Gallon - (est).: | 7.156 to 7.181
|
| Refractive Index: | 1.47000 to 1.47300 @ 20.00 °C.
|
| Melting Point: | 10.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 202.00 °C. @ 760.00 mm Hg
|
| Vapor Pressure: | 0.400000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 149.00 °F. TCC ( 65.00 °C. )
|
| logP (o/w): | 5.640 (est) |
| Soluble in: |
| | water, 0.9891 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | natural substances and extractives |
| Recommendation for cyclodecane usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for cyclodecane flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
Articles:
| PubMed: | Mass transfer and adsorption equilibrium for low volatility alkanes in BPL activated carbon. |
| PubMed: | Reactions of OH radicals with C6-C10 cycloalkanes in the presence of NO: isomerization of C7-C10 cycloalkoxy radicals. |
| PubMed: | Action of Coriandrum sativum L. Essential Oil upon Oral Candida albicans Biofilm Formation. |
| PubMed: | Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. |
| PubMed: | Can (pi)6 + (pi)4 = 10? Exploring cycloaddition routes to highly unsaturated 10-membered rings. |
| PubMed: | Effect of molecular weight, crystallinity, and hydrophobicity on the acoustic activation of polymer-shelled ultrasound contrast agents. |
| PubMed: | Catalytic ring expansion, contraction, and metathesis-polymerization of cycloalkanes. |
| PubMed: | Interconversion of carbon sites in boat-chair-boat cyclodecane; conformations of chlorocyclodecane and cyclodecyl acetate. |
| PubMed: | The C7-C10 cycloalkanes revisited. |
| PubMed: | Ac10c: a medium-ring, cycloaliphatic Calpha,alpha-disubstituted glycine. Incorporation into model peptides and preferred conformation. |
| PubMed: | On ring carbomers of cyclobutane, cyclopentane, and cyclodecane and cyclization reactions through bis(alkynyl-propargyl) coupling. |
| PubMed: | Enhancement of hydrolytic activity of sphingolipid ceramide N-deacylase in the aqueous-organic biphasic system. |
| PubMed: | CAMDAS: an automated conformational analysis system using molecular dynamics. Conformational Analyzer with Molecular Dynamics And Sampling. |
| PubMed: | Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate. |
|